Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-33,419
Closed -$1.79M 693
2022
Q4
$1.79M Sell
33,419
-35,741
-52% -$1.84M 0.01% 427
2022
Q3
$3.19M Buy
69,160
+33,229
+92% +$1.8M 0.01% 359
2022
Q2
$1.98M Sell
35,931
-28,132
-44% -$1.81M 0.01% 411
2022
Q1
$4.39M Buy
+64,063
New +$4.56M 0.02% 285
2021
Q4
Sell
-19,454
Closed -$1.54M 669
2021
Q3
$1.54M Sell
19,454
-40,634
-68% -$3.27M 0.01% 382
2021
Q2
$4.74M Sell
60,088
-66,594
-53% -$5.1M 0.02% 227
2021
Q1
$9.55M Buy
+126,682
New +$9.29M 0.05% 112
2020
Q3
Sell
-23,907
Closed -$1.15M 400
2020
Q2
$1.15M Buy
+23,907
New +$1.06M 0.01% 273
2015
Q4
Sell
-23,476
Closed -$1.21M 228
2015
Q3
$1.21M Hold
23,476
﹤0.01% 157
2015
Q2
$1.86M Buy
+23,476
New +$1.99M 0.01% 150

Other funds holding ENOV

Brookfield Corp's ENOV Position: Q1 2023 in Review

Brookfield Corp sold out of Enovis (ENOV) in Q1 2023, closing a stake of 33,419 shares — an estimated $1.79M sold.

Brookfield Corp first reported a position in ENOV in Q2 2015 and held it in 10 quarters. The position peaked at $9.55M in Q1 2021. 249 funds tracked by Wall St. Rank hold ENOV as of Q1 2023.

  • Brookfield Corp reported no remaining Enovis position as of Q1 2023 after selling out during the quarter.
  • Brookfield Corp sold 33,419 Enovis shares in Q1 2023, an estimated $1.79M.
  • Brookfield Corp first reported a position in Enovis in Q2 2015 and held it in 10 quarters.
  • Brookfield Corp's Enovis position peaked at $9.55M in Q1 2021.
  • 249 funds tracked by Wall St. Rank held Enovis as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.